Assessing the Risk of Contrast-Induced Nephropathy Using a Finger Stick Analysis in Recalls from Breast Screening
| Autor: | Marc B. I. Lobbes, Estelle C. Nijssen, Otto Bekers, Joachim E. Wildberger, C. J. L. Y. van Berlo, I. P. L. Houben |
|---|---|
| Přispěvatelé: | MUMC+: DA BV AIOS Radiologie (9), RS: NUTRIM - R3 - Respiratory & Age-related Health, MUMC+: DA CDL (5), RS: NUTRIM - R4 - Gene-environment interaction, MUMC+: DA BV Klinisch Fysicus (9), Beeldvorming, MUMC+: DA BV Medisch Specialisten Radiologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: DA Beeldvorming (5), RS: CARIM - R3.11 - Imaging |
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
lcsh:Medical technology Article Subject Point-of-Care Systems Contrast-induced nephropathy Contrast Media Renal function ACUTE KIDNEY INJURY Breast Neoplasms Risk Assessment GLOMERULAR-FILTRATION-RATE 030218 nuclear medicine & medical imaging Nephropathy Iodine Radioisotopes 03 medical and health sciences 0302 clinical medicine Internal medicine ENHANCED SPECTRAL MAMMOGRAPHY medicine PROGRAM Humans Mammography Radiology Nuclear Medicine and imaging Risk factor Stage (cooking) Aged medicine.diagnostic_test business.industry Acute kidney injury Middle Aged medicine.disease Surgery lcsh:R855-855.5 030220 oncology & carcinogenesis Cohort Female Kidney Diseases business Research Article |
| Zdroj: | Contrast Media & Molecular Imaging. Wiley Hindawi Partnership Contrast Media & Molecular Imaging, Vol 2017 (2017) Contrast Media & Molecular Imaging |
| ISSN: | 1555-4309 |
| Popis: | Purpose. To evaluate whether a handheld point-of-care (POC) device is able to predict and discriminate patients at potential risk of contrast-induced nephropathy (CIN) prior to iodine-based contrast media delivery. Methods and Materials. Between December 2014 and June 2016, women undergoing contrast-enhanced spectral mammography (CESM) with an iodine-based contrast agent were asked to have their risk of CIN assessed by a dedicated POC device (StatSensor CREAT) and a risk factor questionnaire based on national guidelines. Prior to contrast injection, a venous blood sample was drawn to compare the results of POC with regular laboratory testing. Results. A total of 351 patients were included; 344 were finally categorized as low risk patients by blood creatinine evaluation. Seven patients had a eGFR below 60 ml/min/1.73 m2, necessitating additional preparation prior to contrast delivery. The POC device failed to categorize six out of seven patients (86%), leading to (at that stage) unwanted contrast administration. Two patients subsequently developed CIN after 2–5 days, which was self-limiting after 30 days. Conclusion. The POC device tested was not able to reliably assess impairment of renal function in our patient cohort undergoing CESM. Consequently, we still consider classic clinical laboratory testing preferable in patients at potential risk for developing CIN. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text